Albert Lab
2025-2027, Targeting serotonin to improve depression and dementia in heart and Alzheimer disease. Brain Heart Interconnectome.
2025-2026, Early raphe nucleus pathology and depression with a-syn seeding: A novel approach to targeting mTOR for prodromal Parkinsonism. (PI: Shawn Hayley) Parkinson Research Consortium.
2025-2029, Enhancing neuroplasticity for behavioral and cognitive recovery after stroke. Heart and Stroke Foundation, Canada.
2021-2026, Astroglial cells as mediators of sex and hormone- dependent differences in depressive like behaviours. (PI: Natalina Salmaso) Canadian Institutes of Health Research
2022-2025, Enhancing neuroplasticity for behavioral recovery post-stroke. Heart & Stroke Foundation Canada
2020-2025, Overcoming resistance to antidepressant treatment. Canadian Institutes of Health Research